drugset / Trial / NCT01014572

The Effect of Exercise and Alagebrium on the Diastolic Function of the Heart

NCT01014572 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether an investigational drug (Alagebrium (generic: ALT-711), a type of medication referred to as an advanced glycaton end-product clever) can be combined with exercise training to reverse the stiffening of the heart that takes place naturally with aging.

Timeline

Start
2008-07
Primary completion
2012-06
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject alagebrium Small molecule 100 mg Oral